Advanced search
Publication Cover
Journal of Market Access & Health Policy Volume 5, 2017 - Issue 1
Journal homepage
835
Views
8
CrossRef citations to date
0
Altmetric
Article

Healthcare resource use in schizophrenia, EuroSC findings

A. MillierHealth Economics and Outcomes Research, Creativ-Ceutical, Paris, FranceCorrespondence[email protected]
View further author information
,
M. HorváthMarket Access, Medical & Marketing, Gedeon Richter Plc, Budapest, HungaryView further author information
,
F. MaHealth Economics and Outcomes Research, Creativ-Ceutical, Beijing, ChinaView further author information
,
K. KócziánMarket Access, Medical & Marketing, Gedeon Richter Plc, Budapest, HungaryView further author information
,
A. GötzeMarket Access, Medical & Marketing, Gedeon Richter Plc, Budapest, HungaryView further author information
&
M. ToumiPublic Health Department, Aix-Marseille University, FranceORCID Iconhttp://orcid.org/0000-0001-7939-7204View further author information
ORCID Icon
Article: 1372027 | Received 31 May 2017, Accepted 22 Aug 2017, Published online: 05 Sep 2017

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Aditi Kadakia, Qi Fan, Jason Shepherd, Hollie Bailey, Carole Dembek, Chloe Walker & G. Rhys Williams. (2022) Point-in-time survey of healthcare resource utilization, employment, quality of life and caregiver status by disease severity in patients with schizophrenia in the US. Current Medical Research and Opinion 38:3, pages 469-478.
Read now
Chiraz Azaiez, Aurélie Millier, Christophe Lançon, Emilie Clay, Pascal Auquier, Pierre-Michel Llorca & Mondher Toumi. (2018) Health related quality of life in patients having schizophrenia negative symptoms – a systematic review. Journal of Market Access & Health Policy 6:1.
Read now

Articles from other publishers (6)

Sharon Weber, James G. Scott & Mary Lou Chatterton. (2022) Healthcare costs and resource use associated with negative symptoms of schizophrenia: A systematic literature review. Schizophrenia Research 241, pages 251-259.
Crossref
A. Orrico-Sánchez, M. López-Lacort, C. Muñoz-Quiles, G. Sanfélix-Gimeno & J. Díez-Domingo. (2020) Epidemiology of schizophrenia and its management over 8-years period using real-world data in Spain. BMC Psychiatry 20:1.
Crossref
A. Vita, A.P. Perin, M. Cavanna, F. Cobelli, J. Rosa, P. Valsecchi, M. Zanigni, G. Reggiardo & E. Sacchetti. (2020) Negative symptom severity at discharge from an index hospitalization and subsequent use of psychiatric care resources: A retrospective 1-year follow-up study on 450 patients with schizophrenia spectrum disorders. Schizophrenia Research 216, pages 243-248.
Crossref
Bertalan Németh, Rita Bendes, Balázs Nagy, Árpád Götze, Kristóf Kóczián, Margit Horváth, Izabella Deák, Bernadett Tóth & Zoltán Kaló. (2019) Cost-utility analysis of cariprazine compared to risperidone among patients with negative symptoms of schizophrenia. Health Policy and Technology 8:1, pages 84-91.
Crossref
Agota Barabassy, Balázs Szatmári, István Laszlovszky & György Németh. 2018. Psychotic Disorders - An Update. Psychotic Disorders - An Update.
Emily J. Blanchard & Shushanik Hakobyan. (2013) The U.S. Generalized System of Preferences: In Principle and Practice. SSRN Electronic Journal.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.